Science Market Update

Washington University, St. Louis Leading Drug Trial for Alzheimer's Prevention

Posted by Rebecca Partridge on Tue, Jan 24, 2017

Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”

Read More

Tags: Washington University St. Louis, Washington University, WUSTL, Alzheimer' Research, Alzheimer’s, Research Funding, biotech vendor show, Alzheimer's treatment market, Bioresearch Grant, Biotechnology trade show

U.Mass Amherst Receives $4.8M in Alzheimer's Funding

Posted by Jennifer Nieuwkerk on Tue, Jan 07, 2014

Researchers at the University of Massachusetts Amherst, as part of a multi-institution research team, received $4.8 million in life science funding from the National Cancer Institute as part of a five-year life science grant to research a way to target various diseases including Alzheimer’s, cancer and graft-versus-host disease (GVHD) by changing the function of an enzyme that sets in motion over 100 different protein substrates in the body.

Read More

Tags: 2014, 2013, Northeast, University of Massachusetts Amherst, Massachusetts, BioResearch Product Faire Event, MA, Amherst, cancer treatment market, UMASS, Alzheimer's treatment market

Alzheimer’s Research Market on the Rise at UCSB and Worldwide

Posted by Jennifer Nieuwkerk on Mon, Dec 09, 2013

Researchers at the University of California, Santa Barbara have discovered the age and origin of an E280A gene mutation that has caused early-onset Alzheimer’s in a Columbian family. The family, whose members have had Alzheimer’s with more frequency than most families, was traced to a single founder dating from the 1500’s. The research team sequenced the genomes of more than 100 family members and identified the regions of common ancestry. They then used this information to trace the source of the Alzheimer’s mutation.

Read More

Tags: 2014, CA, 2013, Southwest, BioResearch Product Faire Front Line Event, BioResearch Product Faire Event, UCSB, Santa Barbara, Alzheimer's research market, Alzheimer's treatment market, UC Santa Barbara

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!